Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mei Pharma Inc (MEIP)

Mei Pharma Inc (MEIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mei Pharma Inc 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 USA

www.meipharma.com P: 858-369-7100

Description:

MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company is focused on the clinical development of its two lead isoflavone-based drug candidates, ME-143 and ME-344. MEI Pharma, Inc., formerly known as Marshall Edwards, Inc., is based in San Diego.

Key Statistics

Overview:

Market Capitalization, $K 21,654
Enterprise Value, $K 4,744
Shares Outstanding, K 6,663
Annual Sales, $ 48,820 K
Annual Net Income, $ -31,840 K
Last Quarter Sales, $ 65,300 K
Last Quarter Net Income, $ 56,370 K
EBIT, $ 36,740 K
EBITDA, $ 37,130 K
60-Month Beta 0.77
% of Insider Shareholders 3.90%
% of Institutional Shareholders 52.38%
Float, K 6,403
% Float 96.10%
Short Volume Ratio 0.06

Growth:

1-Year Return -32.71%
3-Year Return -95.30%
5-Year Return -94.91%
5-Year Revenue Growth 2,913.58%
5-Year Earnings Growth 66.08%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.66 on 02/13/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm 6.23
EPS Growth vs. Prev Qtr -119.62%
EPS Growth vs. Prev Year -203.75%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 04/17/23

MEIP Ratios

Ratio
Price/Earnings ttm 1.11
Price/Earnings forward 0.99
Price/Earnings to Growth N/A
Return-on-Equity % 39.72%
Return-on-Assets % 18.26%
Profit Margin % -65.22%
Debt/Equity 0.00
Price/Sales 0.45
Price/Cash Flow N/A
Price/Book 0.36
Book Value/Share 12.22
Interest Coverage -0.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar